Dec 29, 2021

Philips completes cancellation of 33.5 million shares

Amsterdam, the NetherlandsRoyal Philips (NYSE: PHG; AEX: PHIA) today announced that it has completed the cancellation of 33.5 million of its shares. Philips’ current issued share capital amounts to EUR 176,779,793.80 representing 883,898,969 common shares.


The cancelled shares include 20.5 million shares acquired under the EUR 1.5 billion share repurchase program* that was initiated in the first quarter of 2019, and is now completed.

The cancelled shares further include 13.0 million shares that Philips acquired under the ongoing EUR 1.5 billion share buyback program* that was announced on July 26, 2021. These shares were acquired through open market purchases in the fourth quarter of 2021. In the third quarter of 2021, Philips had already entered into a number of forward transactions, covering approximately half of this program, with settlement dates in 2022, 2023 and 2024.


Further details on Philips’ current repurchase program and previous programs can be found here.


* For capital reduction purposes

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being, and enabling better outcomes across the health continuum – from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2020 sales of EUR 17.3 billion and employs approximately 78,000 employees with sales and services in more than 100 countries. News about Philips can be found at

Click here to read moreClick here to read less



Ben Zwirs

Ben Zwirs

Philips Global Press Office

Tel: +31 6 1521 3446

Derya Guzel

Derya Guzel

Philips Investor Relations

Tel: +31 20 59 77055

Press releases

Get our press releases by e-mail

Share on social media

  • Link copied

Our site can best be viewed with the latest version of Microsoft Edge, Google Chrome or Firefox.